Why is Amazon cutting corporate jobs due to AI?
How did Middle East tensions impact oil prices?
What caused the recent plunge in solar stocks?
Why did At Home file for bankruptcy?
How will Kraft Heinz’s dye removal affect products?
Why is the Senate passing a stablecoin regulation bill?
What’s behind JPMorgan’s Sapphire Reserve fee hike?
These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News
benzinga.com/analyst-stock-ratings/price-target/25/06/45982320/these-analysts-revise-their-forecasts-on-sage-therapeutics-following-acquisiti
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) on Monday agreed to acquire Sage Therapeutics, Inc. (NASDAQ:SAGE) for $12.00 per share in cash, or an aggregate of up to approximately $795 million.
The deal consideration includes $8.50 per share in cash (or an aggregate of approximately $561…
This story appeared on benzinga.com, 2025-06-17 18:22:48.